This leadership role involves developing and characterizing drug substance processes to advance programs from Phase II/III through marketing applications.
Base: $184,494.20 - $249,609.80 USD annually; Bonus: Discretionary annual bonus program; Benefits: Retirement plan, medical/dental/vision, stock incentives
Must-have
Nice-to-have
Not specified